Immunochemotherapy against colon cancer by gene transfer of interleukin-12 in combination with oxaliplatin

被引：12
作者：
Hernandez-Alcoceba, Ruben [1 ]
Berraondo, Pedro [1 ]
机构：
[1] Univ Navarra, Div Gene Therapy & Hepatol, CIMA, Fdn Appl Med Res, E-31080 Pamplona, Spain
来源：
ONCOIMMUNOLOGY | 2012年 / 1卷 / 01期
关键词：
interleukin-12; oxaliplatin; colorectal cancer; liver; adenovirus; SUPPRESSOR-CELLS; IMMUNE-SYSTEM; EXPRESSION;
D O I：
10.4161/onci.1.1.17930
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Using a murine model of liver metastases, we found that oxaliplatin can enhance the immunostimulatory effect of interleukin-12 delivered by an adenoviral vector. A shift toward a favorable immune microenvironment was observed in tumors, with a relative increase in CD8(+) T cells vs. T regulatory and myeloid-derived suppressor cells.
引用
收藏
页码：97 / 99
页数：3
相关论文
共 50 条
  • [11] Regression of colon cancer and induction of antitumor immunity by intratumoral injection of adenovirus expressing interleukin-12
    Mazzolini, G
    Qian, C
    Xie, XM
    Sun, YL
    Lasarte, JJ
    Drozdzik, M
    Prieto, J
    CANCER GENE THERAPY, 1999, 6 (06) : 514 - 522
  • [12] An Effective vaccine against colon cancer in mice: Use of recombinant adenoviruses interleukin-12 transduced dendritic cells
    He, Xiao-Zhou
    Wang, Liang
    Zhang, Yan-Yun
    WORLD JOURNAL OF GASTROENTEROLOGY, 2008, 14 (04) : 532 - 540
  • [13] An effective vaccine against colon cancer in mice:Use of recombinant adenovirus interleukin-12 transduced dendritic cells
    Xiao-Zhou He
    World Journal of Gastroenterology, 2008, (04) : 532 - 540
  • [14] Interleukin-12 gene therapy vaccines: Directing the immune system against minimal residual leukemia
    Dunussi-Joannopoulos, K
    Leonard, JP
    LEUKEMIA & LYMPHOMA, 2001, 41 (5-6) : 483 - +
  • [15] An in silico exploration of combining Interleukin-12 with Oxaliplatin to treat liver-metastatic colorectal cancer
    Wang, Qing
    Wang, Zhijun
    Wu, Yan
    Klinke, David J., II
    BMC CANCER, 2020, 20 (01)
  • [16] Cancer Electrogene Therapy with Interleukin-12
    Cemazar, Maja
    Jarm, Tomaz
    Sersa, Gregor
    CURRENT GENE THERAPY, 2010, 10 (04) : 300 - 311
  • [17] Serum levels of interleukin-12 in patients with gastrointestinal cancer
    Nakayama, Y
    Shibao, K
    Sako, T
    Ohta, R
    Onitsuka, K
    Hirata, K
    Nagata, N
    Itoh, H
    ANTICANCER RESEARCH, 2000, 20 (1C) : 635 - 640
  • [18] Synergistic antitumor effects of interleukin-12 gene transfer and systemic administration of interleukin-18 in a mouse bladder cancer model
    Kazuki Yamanaka
    Isao Hara
    Hiroshi Nagai
    Hideaki Miyake
    Kazuo Gohji
    Mark J. Micallef
    Masashi Kurimoto
    Soichi Arakawa
    Sadao Kamidono
    Cancer Immunology, Immunotherapy, 1999, 48 : 297 - 302
  • [19] Synergistic antitumor effects of interleukin-12 gene transfer and systemic administration of interleukin-18 in a mouse bladder cancer model
    Yamanaka, K
    Hara, I
    Nagai, H
    Miyake, H
    Gohji, K
    Micallef, MJ
    Kurimoto, M
    Arakawa, S
    Kamidono, S
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 1999, 48 (06) : 297 - 302
  • [20] Interleukin-12 and interleukin-2 alone or in combination against the infection in invasive pulmonary aspergillosis mouse model
    Zhang, Chang-Ran
    Lin, Jian-Cong
    Xu, Wen-Ming
    Li, Ming
    Ye, Hui-Shao
    Cui, Wei-Ling
    Lin, Qing
    MYCOSES, 2013, 56 (02) : 117 - 122
12345